Rankings
▼
Calendar
FOLD Q3 2022 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$82M
+2.7% YoY
Gross Profit
$68M
83.6% margin
Operating Income
-$34M
-41.4% margin
Net Income
-$33M
-40.7% margin
EPS (Diluted)
$-0.12
QoQ Revenue Growth
+1.2%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$11M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$760M
Total Liabilities
$627M
Stockholders' Equity
$133M
Cash & Equivalents
$278M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$82M
$80M
+2.7%
Gross Profit
$68M
$68M
+0.6%
Operating Income
-$34M
-$42M
+20.2%
Net Income
-$33M
-$50M
+33.8%
Geographic Segments
Non-US
$51M
63%
UNITED STATES
$30M
37%
← FY 2022
All Quarters
Q4 2022 →